Millions of Medicare Recipients Could Gain Access to Weight-Loss Drug
Millions of overweight or obese patients with heart conditions insured under Medicare could gain access to a popular weight-loss drug, a study has found. Novo Nordisk's Wegovy, chemically known as semaglutide, was approved by the U.S. Food and Drug …